PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial Cancer
Clinical trial NCT06549855 · RECRUITING
Trial details
- NCT number
- NCT06549855
- Sponsor
- Peking University People's Hospital
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-02
- Primary completion
- 2029-07-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.